Literature DB >> 24860933

Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm.

Christopher Abela1, Christoph E A Hartmann2, A De Leo1, Anna de Sica Chapman3, Hetul Shah3, Mohammad Jawad1, Christopher B Bunker3, Greg J P Williams1, Jorge Leon-Villapalos1.   

Abstract

Toxic epidermal necrolysis syndrome (TEN) is a potentially catastrophic exfoliative muco-cutaneous disorder first described by Lyell in 1956. It represents the most extensive form of Steven-Johnson syndrome. TEN is defined varyingly around the globe, but in the United Kingdom the consensus opinion describes the process as involving >30% of the total body surface area. It can rapidly become more extensive and threatens life. The estimated annual incidence is approximately 1-2 cases per million population. The risk of mortality increases with surface area involved and meta-analysis of the literature shows this risk to be between 16% and 55%. Over a six month period the Chelsea and Westminster Hospital Burns Service treated five consecutive patients with more than 80% total body surface area involvement or a more than 80% mortality risk, using the severity-of-illness score for toxic epidermal necrolysis (SCORTEN). All patients were treated according to the Chelsea and Westminster Hospital wound management algorithm with excellent outcome and no mortalities. The aim of this paper is to propose a generic TEN wound management algorithm according to the severity of skin lesions, using a simple wound grading system.
Copyright © 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Grading; Steven–Johnson syndrome; TEN; Toxic epidermal necrolysis syndrome; Wound care; Wound management

Mesh:

Substances:

Year:  2014        PMID: 24860933     DOI: 10.1016/j.bjps.2014.04.003

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  7 in total

Review 1.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

Review 2.  Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.

Authors:  Stefanie Zimmermann; Peggy Sekula; Moritz Venhoff; Edith Motschall; Jochen Knaus; Martin Schumacher; Maja Mockenhaupt
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

3.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses.

Authors:  Leah M Hanson; Amanda P Bettencourt
Journal:  AACN Adv Crit Care       Date:  2020-09-15

4.  Stevens-Johnson Syndrome.

Authors:  Jake Laun; Katie Laun; Mayssan Muftah; Amanda Zimmerman; Joshua B Elston; David J Smith
Journal:  Eplasty       Date:  2016-12-07

5.  Management of Toxic Epidermal Necrolysis with Plasmapheresis and Cyclosporine A: Our 10 Years' Experience.

Authors:  Giuseppe Giudice; Giulio Maggio; Loredana Bufano; Giuseppe Memeo; Michelangelo Vestita
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-02-22

6.  Autologous scalp skin grafting to treat toxic epidermal necrolysis in a patient with a large skin injury: A case report.

Authors:  Dong-Dong Xue; Ling Zhou; Yong Yang; Si-Yuan Ma
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

Review 7.  Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies.

Authors:  Yanping Li; Ruoqiu Fu; Tingting Jiang; Dongyu Duan; Yuanlin Wu; Chen Li; Ziwei Li; Rui Ni; Li Li; Yao Liu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.